Invex Therapeutics Ltd
ASX:IXC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Invex Therapeutics Ltd
ASX:IXC
|
AU |
|
H
|
Hostmore PLC
LSE:MORE
|
UK |
|
Nittoku Co Ltd
TSE:6145
|
JP |
|
Croma Security Solutions Group PLC
LSE:CSSG
|
UK |
|
L
|
Loxley PCL
SET:LOXLEY
|
TH |
|
C
|
Concert Pharmaceuticals Inc
F:73C
|
US |
|
B
|
Barito Renewables Energy PT Tbk
IDX:BREN
|
ID |
|
Dharma Satya Nusantara Tbk PT
IDX:DSNG
|
ID |
|
W
|
Wot Co Ltd
KOSDAQ:396470
|
KR |
|
Pradeep Metals Ltd
BSE:513532
|
IN |
|
Wonderful Sky Financial Group Holdings Ltd
HKEX:1260
|
HK |
|
MineralRite Corp
OTC:RITE
|
US |
|
Judo Capital Holdings Ltd
ASX:JDO
|
AU |
|
S
|
Shengjing Bank Co Ltd
HKEX:2066
|
CN |
|
Information Services International-Dentsu Ltd
TSE:4812
|
JP |
|
Bell Financial Group Ltd
ASX:BFG
|
AU |
|
D
|
Daeyang Electric Co Ltd
KOSDAQ:108380
|
KR |
Bankruptcy Probability
Invex Therapeutics Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Invex Therapeutics Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
Invex Therapeutics Ltd
ASX:IXC
|
7.5m AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
161B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Invex Therapeutics Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Invex Therapeutics Ltd has no debt.
You can find a full breakdown on its Balance Sheet.
